Comparison of the Efficacy and Safety of Insulin Glargine and Insulin Detemir with NPH Insulin in Children and Adolescents with Type 1 Diabetes Mellitus Receiving Intensive Insulin Therapy <br />

Journal Title: Journal of Clinical Research in Pediatric Endocrinology - Year 2009, Vol 1, Issue 4

Abstract

Objective: The purpose of this study was to compare the efficacy and safety of insulin glargine and detemir with NPH insulin in children and adolescents with type 1 diabetes mellitus (DM). Methods: Thirty four children and adolescents with type 1 DM (mean age 12.7 ± 3.4 years, diabetes duration 5.4 ± 3.0 years) were included in the study. All patients had been receiving intensive insulin therapy with insulin aspart and NPH for at least 6 months before switching from NPH to insulin glargine (Group 1, n=19) or detemir (Group 2, n=15). The medical records obtained within 6 months before and after treatment with insulin glargine and detemir were retrospectively reviewed and the data were compared in each group. Results: The mean age and duration of DM were similar in two groups (p&gt;0.05). In both groups, switching from NPH to insulin glargine or detemir, resulted in a reduction in HbA1c (p0.05, for both). Patients in the detemir treated group had less increment in body mass index (BMI) SDS at the end of 6 months of therapy compared to NPH and glargine treated patients (p&gt;0.05, for both). No side effects were noted throughout the study. Conclusion: Both insulin glargine and detemir improved HbA1c at short-term and proved to be safe and well tolerated in children and adolescents with type 1 DM. DOI: 10.4008/jcrpe.v1i4.56

Authors and Affiliations

Bumin Dündar, Nihal Dündar, Erdal Eren

Keywords

Related Articles

A Novel Mutation Causing Pseudohypoparathyroidism 1A with Congenital Hypothyroidism and Osteoma Cutis

Various inactivating mutations in guanine nucleotide-binding protein, alpha-stimulating activity polypeptide1 (GNAS1) gene have been described with poor phenotype correlation. Pseudohypoparathyroidism type 1a (PHP1a) res...

Prevalence of Cryptorchidism Among Bulgarian Boys

Background: Cryptorchidism is the most common congenital defect of the male urogenital system. It may be an important cause for male infertility. The data about its prevalence in South-eastern European countries and espe...

Myasthenia Gravis Hasta Timektomi sonra Otoimmün ooforit Kararı

Myastenia gravis (MG), asetilkolin reseptörlerine karşı otoantikorlar ile karakterize otoimmün bir hastalıktır . MG genellikle izole bir hastalık ama diğer otoimmün hastalıklar ile birlikte oluşabilir. Biz, sekonder amen...

Inflammatory Cytokine Profiles During Exercise in Obese, Diabetic, and Healthy Children

Objective: Modulation of inflammatory status is considered a key component of the overall health effects of exercise. This may be especially relevant in children with obesity (Ob) or type 1 diabetes (T1DM), in which an i...

Hypothalamo-Pituitary Insufficiency Associated with Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome

Ectrodactyly-ectodermal dysplasia-clefting (EEC) syndrome is characterized by ectodermal dysplasia, ectrodactyly and facial clefting with multiple congenital anomalies such as urinary tract anomaly, lacrimal duct obstruc...

Download PDF file
  • EP ID EP123891
  • DOI -
  • Views 101
  • Downloads 0

How To Cite

Bumin Dündar, Nihal Dündar, Erdal Eren (2009). Comparison of the Efficacy and Safety of Insulin Glargine and Insulin Detemir with NPH Insulin in Children and Adolescents with Type 1 Diabetes Mellitus Receiving Intensive Insulin Therapy <br /> . Journal of Clinical Research in Pediatric Endocrinology, 1(4), 181-187. https://europub.co.uk/articles/-A-123891